Preliminary Scientific Programme

Saturday, November 14, 2009
Japanese Educational Day

09:00 – 11:30	Symposium 1; Centralization of blood services and securing of stable blood supply
	Symposium 2; Information technology in blood transfusion therapy and blood programme
13:00 – 16:00	Symposium 3; Consolidation of testing and preparation sections of blood centers: Influences on stable supply of safe blood products
	Symposium 4; Blood transfusion safety: Roles of hospital medical directors and transfusion specialists
16:00 – 18:00	Symposium 5; New approaches for paediatric transfusion

Sunday, November 15, 2009
ISBT Academy Programme (1)

09:00 – 10:30	HAEMOSTASIS Strategies for blood transfusion in critical bleeding – Eiichi Inada (Japan) Heparin-induced thrombocytopenia (HIT) – Shigeki Miyata (Japan) Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998- 2008 – Yoshihiro Fujimura (Japan)
10:30 – 11:00	COFFEE BREAK
11:00 – 12:30	TTID Emerging infections in Asia and its possible global effects – Peter Flanagan (New Zealand) Changing concept of Hepatitis B virus worldwide – Masashi Mizokami (Japan) vCJD and its consequences for the Asia-Pacific Region – Tony Keller (Australia)
12:30 – 14:30	LUNCH BREAK AND SATELLITE SYMPOSIA
14:30 – 16:00	STEM CELLS AND TRANSPLANTATION Stem cell harvesting and transplantation – Wolfgang Mayr (Austria) Allogeneic haematopoetic stem cell transplantation: an Asian perspective – Raymond Liang (Hong Kong SAR, China) Worldwide network for blood and marrow transplantation (WBMT) – Yoshihsa Kodera (Japan)
16:00 – 16:30	COFFEE BREAK
16:30 – 18:00	TRANSFUSION PRACTICE Hospital transfusion committee – the essentials for safe and proper transfusion medicine – Koki Takahashi (Japan) Blood transfusions in neonatal cardiac surgery and extracorporeal membrane oxygenator (ECMO) – Anneke Brand (The Netherlands) Transfusion errors and their prevention – Mickey Koh (Singapore)

Sunday, November 15, 2009
ISBT Academy Programme (2)

09:00 - 10:30	SAFE BLOOD Prevention of bacterial contamination – Erica Wood (Australia) Transfusion related immune reactions: Pathogenesis and prevention – Norbert Ahrens (Germany) TA-GVHD: Universal irradiation on blood components – Takeo Juji (Japan)
10:30 - 11:00	COFFEE BREAK
11:00 - 12:30	IMMUNO-HAEMATOLOGY Update on current issues in the immune response in Transfusion Medicine – Anne Husebekk (Norway) Non-invasive detection of fetal RhD status and other genetic characteristics by circulating nucleic acids in maternal plasma – Dennis Lo (Hong Kong SAR, China) Leukocyte antibody screening of donors for the prevention of TRALI – Juergen Bux (Germany)
12:30 - 14:30	LUNCH BREAK AND SATELLITE SYMPOSIA
14:30 - 16:00	BLOOD PRODUCTS/MANAGEMENT Provision of blood products for the highly immunized patient – Sandra Nance (USA) Cost-effectiveness in hemotherapies and transfusion medicine – Axel Hoffman (Austria) Extending platelet storage: safety and quality considerations – Hitoshi Ohto (Japan)
16:00 - 16:30	COFFEE BREAK
16:30 - 18:00	DONOR RECRUITMENT AND DONOR CARE Collaboration of stakeholders for promotion of Voluntary Non-Remunerated Blood Donors – Kenji Tadokoro (Japan) Donor management: social marketing, maintenance and trust – Cecilia Tan (Singapore) Quality Assurance in Blood Banking: the basis for safety – Vee Armstrong (Australia)

Monday, November 16, 2009

09:00 - 10:30	S1: MANAGEMENT AND ORGANISATION Risk and crisis management in blood programme – Che Kit Lin (Hong Kong SAR, China)
	S2: TTI Prevalence of HEV infection among Japanese blood donors – Hisami Ikeda (Japan)
	S3: BLOOD DONATION Current status and challenge of donor recruitment – Sujen Lin (Taiwan)
10:30 - 11:00	COFFEE BREAK
11:00 - 12:30	Plenary Session on Cellular Therapies From human somatic cells to human iPS cells - State of the art and future needs – Kazuhiro Sakurada (Japan) Heterogeneity and Hierarchy Within the Most Primitive Hematopoietic Stem Cell Compartment – Hiromitsu Nakauchi (Japan)
12:30 - 13:30	GENERAL ASSEMBLY
13:30 - 15:30	LUNCH BREAK AND SATELLITE SYMPOSIA
15:30 - 17:00	S4: TTI NAT screening and pathogen inactivation for blood products – Erhard Seifried (Germany) From NAT/PI to NAS/PO: Preparing for Nucleic Acid Surveillance and Product Optimization – Ken Nollet (Japan)
	S5: IMMUNE HAEMATOLOGY Molecular biology of blood groups – Geoff Daniels (United Kingdom)
	S6: CELLULAR THERAPIES Unrelated hematopoietic stem cell transplantation and bank – Yasuo Morishima (Japan) Cord Blood Transplantation: Experience in IMSUT – Satoshi Takahashi (Japan)
17:00 - 17:30	COFFEE BREAK
17:30 - 19:00	S:7 CLINICAL TRANSFUSION Evidence based transfusion: a paradigm shift in getting support of evidence needed? – Richard Benjamin (USA) Massive transfusion and haemostais – Jyunki Takamatsu (Japan)
	S8: BLOOD PRODUCTS Managing fractionated products in developing countries – Yasmin Ayob (Malaysia)
	S9: MANAGEMENT AND ORGNISATION What does it really cost to transfuse a unit of red cells? The Australian cost of transfusion study – Erica Wood (Australia) Blood supply management in an influenza pandemic – Diana Teo (Singapore)

Tuesday, November 17, 2009

08:00 - 09:00	BREAKFAST SESSION Transfusion Associated Graft vs. Host Disease and TRALI - Paul Holland (USA)
09:00 - 10:30	S10: BACTERIAL CONTAMINATION Effect and limit of the initial flow diversion – Masahiro Satake (Japan)
	S11: BLOOD PRODUCTS Washed/replaced platelet concentrates – Hiroshi Azuma (Japan)
	S12: CELLULAR THERAPIES Cellular Therapy in Hematological diseases and solid tumors – Erhard Seifried (Germany)
10:30 - 11:00	COFFEE BREAK
11:00 - 12:30	Plenary Session on TTI Occult Hepatitis B infection: incidence, detection and clinical implications – C.L. Lai (Hong Kong SAR, China) Epidemiology, clinical features, and prevention of HTLV-1 infection – Kazuo Tajima (Japan)
12:30 - 14:30	LUNCH BREAK AND SATELLITE SYMPOSIA
14:30 - 16:00	S13: TTI Recent findings and developments of dengue and chikungunya epidemiology and their potential impact on donors and patients - Ng Lee-Ching (Singapore)
	S14: BLOOD DONATION Global consultation on voluntary non-remunerated blood donation – Neelam Dhingra (WHO)
	S15: CLINICAL TRANSFUSION Fight against TRALI ( recent advances) - Hitoshi Okazaki (Japan)
16:00 - 16:30	COFFEE BREAK
16:30 - 18:00	S16: NOVEL DEVELOPMENTS In Vitro production of transfusable red blood cells – Yukio Nakamura (Japan) Novel therapeutic strategy in patients who require repeated transfusion of human leukocyte antigen-matched platelets derived from human induced pluripotent stem cells – Hiroyuki Eto (Japan)
	S17: CLINICAL TRANSFUSION Establishment and outcome of haemovigilance – Pierre Robillard (Canada) Transfusion errors and their prevention – Akimichi Ohsaka (Japan)
	S18: NOVEL DEVELOPMENTS The introduction of Western medicine and bloodletting to Japan – Paul Schmidt (USA) Transfusion medicine and blood program in Japan since Word War II – Masaru Shimizu (Japan)
18:00	POSTERWALKS
19:00	CONGRESS BANQUET

Wednesday, November 18, 2009

09:00 - 10:30	S19: MANAGEMENT AND ORGANISATION Cost effectiveness of blood programmes – Asia Pacific Blood Network perspective – Sally Thomas (Australia)
	S20: NOVEL DEVELOPMENTS Research and development of hemoglobin vesicle, a cellular type artificial oxygen carrier - Hirohisa Horinouchi (Japan) Artificial platelets and platelet substitutes - M. Handa (Japan)
	S21: BLOOD DONATION Donor complication and donor care – vasovagal reaction and preventive measures – Kazunori Nakajima (Japan) Donor Care: the Change We Need – Soisaang Phikulsod (Thailand)
10:30 - 11:00	COFFEE BREAK
11:00 - 12:30	PLENARY SESSION Clinical Transfusion Patient Blood Management – a new paradigm for transfusion? – Amanda Thomson (Australia) Translational Research: an important integrated paradigm for transfusion medicine – Steven Kleinman (Canada)
12:30 - 13:00	CLOSING CEREMONY